Reduce marketing costs, harness the full potential of data with ARTis

Problem Statement

In the competitive landscape of IVF centers, attracting high-quality leads is crucial for growth. Marketing teams invest heavily in campaigns to generate these leads, often at a significant cost. However, not all leads convert into registrations, and even fewer progress to cycle advisories and allocations. For example, starting with 1,000 leads might result in 200 case files, leading to 40 cycle advisories and, eventually, 20 cycle allocations. This means that for every cycle, you need 50 leads, which translates into even more clicks and impressions at the top of the funnel.

The conversion rates depicted in the funnel below are aspirational and not easily achieved. Enhancing patient-centric services is critical to improving these conversions, which is vital for the success of any IVF center.

Considering the high cost of lead acquisition, IVF centers need to ask themselves: How can we reduce this cost? What tools are available to help us achieve this? And how effective and easy are these tools to implement?

ARTis Solution: Leveraging Your Patient Data

IVF success rates hover around 50%, while IUIs succeed only about 10% of the time. Even after multiple cycles, some patients may still struggle to achieve pregnancy. By carefully analyzing patient data and offering alternative solutions, IVF centers can increase the number of cycles while providing top-notch service.

ARTis offers smart reports that detail patients’ cycle histories and outcomes, enabling your center’s operations team to identify opportunities for further engagement. The goal is to maximize additional cycles from your existing patient base, ensuring they receive the best possible care while also improving your center’s conversion rates. Given the high cost of acquiring new leads, focusing on existing patients is a more cost-effective strategy.

Key Opportunities to Maximize IVF Center Potential

1. IUI Failures:

• Follow-up Cycles: Patients who have undergone a single IUI cycle can be encouraged to pursue additional cycles if clinical indicators suggest a reasonable chance of success.
• Alternative Treatments: For patients with multiple unsuccessful IUIs, consider advising Artificial Insemination with Donor or IVF as more suitable options, depending on patient preferences.

2. IVF Failures:

• Additional FET: Recommend further Frozen Embryo Transfer (FET) cycles for patients with failed IVF attempts.
• Stimulation Cycles: For cycles canceled during OPU, consider advising additional stimulation cycles.
• Package Options: Offer tailored packages, including multi-stage options, to ensure continuous service until a successful outcome is achieved.

Analyzing failed IVF cases and offering discounts on additional cycles can significantly impact your bottom line, proving more financially viable than acquiring new leads.

3. Advanced Options:

• Upselling Opportunities: Leverage patient data to offer advanced services like PGD, PGS, and PGT, which, although costly, may be appealing to patients seeking higher chances of success.

4. Donor Packages:

• Alternative Solutions: When self-gametes are no longer viable, offer Donor or Embryo adoption packages. Transparent communication with patients is essential here to ensure compliance with legal requirements and patient satisfaction.

ARTis provides tools to effectively manage consents and track donors, ensuring a seamless and compliant donor cycle process.

5. Surrogacy:

• Advisory Role: Based on clinical conditions, recommend surrogacy and coordinate with a surrogacy service provider in accordance with regional regulations.

Conclusion

Marketing is just one of the three primary referral channels, alongside referrals from doctors and word of mouth. IVF centres are increasingly spending more on marketing to attract quality leads, driving up acquisition costs. While these efforts are necessary, it’s equally important to focus on existing patients who have yet to achieve a successful outcome. ARTis equips IVF centres with smart analytical tools to identify cross-selling and upselling opportunities within their existing patient base, significantly lowering acquisition costs and enhancing the financial performance of the centre.